Including acquisition costs and other charges, Life Technologies said it earned 22 cents per share in the most recent quarter. During the period it also agreed to sell its interest in Applied Biosystems/MDS Sciex, a mass spectrometry business, to Danaher Corp.Life Technologies now forecasts a profit of $2.90 to $2.95 per share, up from between $2.70 and $2.80 per share. That includes a "modest" benefit from stimulus funds. Analysts were expecting $2.80 per share. In morning trading, its stock rose $2.21, or 4.7 percent, to $49.26. They reached a high of $49.94.
Life Technologies Says Demand Held Up In 3Q
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts